Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06158620 | Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease | PHASE2 | RECRUITING | 80 | — | — | Mar 1, 2025 | Dec 1, 2026 | Apr 18, 2025 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| intra-nasal ketorolac | DRUG | Experimental group receiving intra-nasal ketorolac for management of post-operative pain following ureteroscopy for kidney stone, and associated ureter stent discomfort. |
| oral diclofenac | DRUG | Control group to receive oral diclofenac, which is a comparable medication to intra-nasal ketorolac. |